Chromosome 11q13.3 variant modifies renal cell cancer risk in a Chinese population

Mutagenesis

Volumn 27, Issue 3, 2012, Pages 345-350

  Cao, Qiang ^a   Qin, Chao ^a   Ju, Xiaobing ^a   Meng, Xiaoxin ^a   Wang, Meilin ^b   Zhu, Jian ^a   Li, Pu ^a   Chen, Jiawei ^a   Zhang, Zhengdong ^b   Yin, Changjun ^a  

^a THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; BODY WEIGHT; CANCER RISK; CANCER SUSCEPTIBILITY; CHINESE; CHROMOSOME 11Q; CHROMOSOME 11Q13.3; CHROMOSOME POLYMORPHISM; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HISTOLOGY; HUMAN; HUMAN TISSUE; KIDNEY CARCINOMA; KIDNEY PARENCHYMA; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; SMOKING;

ASIAN CONTINENTAL ANCESTRY GROUP; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CARCINOMA, RENAL CELL; CASE-CONTROL STUDIES; CHROMOSOMES, HUMAN, PAIR 11; CYCLIN D1; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTO-ONCOGENE PROTEINS; RISK FACTORS; SCAVENGER RECEPTORS, CLASS B; SEQUENCE ANALYSIS, DNA; TRANSCRIPTION, GENETIC;

EID: 84859436449     PISSN: 02678357     EISSN: 14643804     Source Type: Journal    
DOI: 10.1093/mutage/ger085     Document Type: Article

References (24)

1. Chow, W. H., Dong, L. M. and Devesa, S. S. (2010) Epidemiology and risk factors for kidney cancer. Nat. Rev. Urol., 7, 245-257
2. Jemal, A., Siegel, R., Xu, J. and Ward, E. (2010) Cancer statistics, 2010. CA Cancer J. Clin., 60, 277-300
3. Stö rkel, S., Eble, J. N., Adlakha, K., Amin, M., Blute, M. L., Bostwick, D. G., Darson, M., Delahunt, B. and Iczkowski, K. (1997) Classification of renal cell carcinoma: Workgroup No. 1. Union Internationale Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC). Cancer, 80, 987-989
4. Yang, L., Parkin, D. M., Ferlay, J., Li, L. and Chen, Y. (2005) Estimates of cancer incidence in China for 2000 and projections for 2005. Cancer Epidemiol. Biomarkers Prev., 14, 243-250
5. Cohen, H. T. and McGovern, F. J. (2005) Renal-cell carcinoma. N. Engl. J. Med., 353, 2477-2490
6. Drucker, B. J. (2005) Renal cell carcinoma: current status and future prospects. Cancer Treat. Rev., 31, 536-545
7. Baldewijns, M. M., van Vlodrop, I. J., Vermeulen, P. B., Soetekouw, P. M., van Engeland, M. and de Bruïne, A. P. (2010) VHL and HIF signalling in renal cell carcinogenesis. J. Pathol., 221, 125-138
8. Pouyssegur, J., Dayan, F. and Mazure, N. M. (2006) Hypoxia signalling in cancer and approaches to enforce tumour regression. Nature, 441, 437-443
9. Zhong, H., De Marzo, A. M., Laughner, E. et al. (1999) Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases. Cancer Res., 59, 5830-5835
10. Ollerenshaw, M., Page, T., Hammonds, J. and Demaine, A. (2004) Polymorphisms in the hypoxia inducible factor-1alpha gene (HIF1A) are associated with the renal cell carcinoma phenotype. Cancer Genet. Cytogenet., 153, 122-126
11. Zhu, J., Meng, X., Yan, F. et al. (2010) A functional epidermal growth factor (EGF) polymorphism, EGF serum levels and renal cell carcinoma risk in a Chinese population. J. Hum. Genet., 55, 236-240
12. Bruyère, F., Hovens, C. M., Marson, M. N., d'Arcier, B. F., Costello, A. J., Watier, H., Linassier, C. and Ohresser, M. (2010) VEGF polymorphisms are associated with an increasing risk of developing renal cell carcinoma. J. Urol., 184, 1273-1278
13. Thomas, G., Jacobs, K. B., Kraft, P. et al. (2009) A multistage genomewide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1). Nat. Genet., 41, 579-584
14. Rothman, N., Garcia-Closas, M., Chatterjee, N. et al. (2010) A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci. Nat. Genet., 42, 978-984
15. Hardy, J. and Singleton, A. (2009) Genomewide association studies and human disease. N. Engl. J. Med., 360, 1759-1768
16. Purdue, M. P., Johansson, M., Zelenika, D. et al. (2011) Genome-wide association study of renal cell carcinoma identifies two susceptibility loci on 2p.21 and 11q13.3. Nat. Genet., 43, 60-65
17. Cao, Q., Qin, C., Meng, X. et al. (2011) Genetic polymorphisms in APE1 are associated with renal cell carcinoma risk in a Chinese population. Mol. Carcinog., 50, 863-870
18. Zhu, J., Qin, C., Wang, M. et al. (2010) Functional polymorphisms in cell death pathway genes and risk of renal cell carcinoma. Mol. Carcinog., 49, 810-817
19. Strauss, M., Lukas, J. and Bartek, J. (1995) Unrestricted cell cycling and cancer. Nat. Med., 1, 1245-1246
20. Zhou, Q., Hopp, T., Fuqua, S. A. and Steeg, P. S. (2001) Cyclin D1 in breast premalignancy and early breast cancer: implications for prevention and treatment. Cancer Lett., 162, 3-17
21. Gansauge, S., Gansauge, F., Ramadani, M., Stobbe, H., Rau, B., Harada, N. and Beger, H. G. (1997) Overexpression of cyclin D1 in human pancreatic carcinoma is associated with poor prognosis. Cancer Res., 57, 1634-1637
22. Hedberg, Y., Davoodi, E., Roos, G., Ljungberg, B. and Landberg, G. (1999) Cyclin-D1 expression in human renal-cell carcinoma. Int. J. Cancer, 84, 268-272
23. Hedberg, Y., Ljungberg, B., Roos, G. and Landberg, G. (2003) Expression of cyclin D1, D3, E, and p.27 in human renal cell carcinoma analysed by tissue microarray. Br. J. Cancer, 88, 1417-1423
24. Hirschhorn, J. N., Lohmueller, K., Byrne, E. and Hirschhorn, K. (2002) A comprehensive review of genetic association studies. Genet. Med., 4, 45-61